Share chart AxoGen
Extended chart
Simple chart
About AxoGen
AxoGen — разработчик хирургических решений, в том числе трансплантатов тканей человека, базируется в Алачуа, Флорида. Продукция Axogen предназначена для лечения повреждений периферических нервов. В 2013 году компания привлекла 18 миллионов долларов в ходе первичного публичного размещения акций.Main settings
IPO date
1990-03-27
ISIN
US05463X1063
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
32.79
Дивиденд ао
1
Сайт
Grade
Underestimation
Title | Value | Grade |
P/S | 3.9 | 4 |
P/BV | 7.02 | 1 |
P/E | 0 | 0 |
Efficiency
Title | Value | Grade |
ROA | -4.98 | 0 |
ROE | -9.99 | 0 |
ROIC | -17.66 | 0 |
Dividends
Title | Value | Grade |
Dividend yield | 0 | 0 |
DSI | 0.8333 | 8.33 |
Average dividend growth | 28.09 | 10 |
Debt
Title | Value | Grade |
Debt/EBITDA | 11.3 | 0 |
Debt/Ratio | 0.3371 | 10 |
Debt/Equity | 0.9607 | 9 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | 66.82 | 8 |
Yield Ebitda, % | -130.7 | 0 |
Yield EPS, % | -61.38 | 0 |
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 10.04 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
Week | 10.92 $ | 0 $ | 0 $ | -8.06 % | 0 % | 0 % |
Month | 10.94 $ | 0 $ | 0 $ | -8.23 % | 0 % | 0 % |
Three month | 16.76 $ | 10.04 $ | 17.13 $ | -40.1 % | 0 % | 0 % |
Half a year | 18.08 $ | 10.04 $ | 20.11 $ | -44.47 % | 0 % | 0 % |
Year | 12.71 $ | 7.8 $ | 20.11 $ | -21.01 % | 0 % | 0 % |
3 years | 9.58 $ | 3.54 $ | 20.11 $ | +4.8 % | 0 % | 0 % |
5 years | 17.26 $ | 3.54 $ | 23.29 $ | -41.83 % | 0 % | 0 % |
10 years | 5.02 $ | 3.35 $ | 55.85 $ | +100 % | 0 % | 0 % |
Year to date | 18.89 $ | 10.04 $ | 20.11 $ | -46.85 % | 0 % | 0 % |
Insider trading
Main owners
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Ms. Doris Quackenbush | Vice President of Sales | N/A | |
Mr. Marc A. Began | Executive VP, General Counsel & Chief Compliance Officer | N/A | 1968 (57 years) |
Mr. Jens Schroeder Kemp | Chief Marketing Officer | N/A | |
Mr. Erick DeVinney | Chief Innovation Officer | N/A | 1976 (49 years) |
Mr. Harold D. Tamayo | Vice President of Finance & Investor Relations | N/A | |
Dr. Ivica Ducic M.D., Ph.D. | Chief Medical Officer | N/A | |
Mr. Todd Puckett | Vice President of Operations | ||
Ms. Karen Zaderej | Advisor | 1962 (63 years) |
About company
Address: United States, Alachua, 13631 Progress Boulevard - Open in google maps, Open in yandex maps
Website: http://www.axogeninc.com
Website: http://www.axogeninc.com